1. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Issue 10093 (29th July 2017) Authors: Kanes, Stephen; Colquhoun, Helen; Gunduz-Bruce, Handan; Raines, Shane; Arnold, Ryan; Schacterle, Amy; Doherty, James; Epperson, C Neill; Deligiannidis, Kristina M; Riesenberg, Robert; Hoffmann, Ethan; Rubinow, David; Jonas, Jeffrey; Paul, Steven; Meltzer-Brody, Samantha Journal: Lancet Issue: Volume 390:Issue 10093(2017) Page Start: 480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Issue 10152 (22nd September 2018) Authors: Meltzer-Brody, Samantha; Colquhoun, Helen; Riesenberg, Robert; Epperson, C Neill; Deligiannidis, Kristina M; Rubinow, David R; Li, Haihong; Sankoh, Abdul J; Clemson, Christine; Schacterle, Amy; Jonas, Jeffrey; Kanes, Stephen Journal: Lancet Issue: Volume 392:Issue 10152(2018) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache. (October 2022) Authors: Riesenberg, Robert; Gaul, Charly; Stroud, Chad E; Dong, Yan; Bangs, Mark E; Wenzel, Richard; Martinez, James M; Oakes, Tina Myers Journal: Cephalalgia Issue: Volume 42:Number 11/12(2022) Page Start: 1225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial. (March 2020) Authors: Riesenberg, Robert; Werth, John; Zhang, Yao; Duvvuri, Sridhar; Gray, David Journal: Therapeutic advances in neurological disorders Issue: Volume 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics and Safety of Single‐Dose Inhaled Loxapine in Children and Adolescents. (16th May 2017) Authors: Selim, Sally; Riesenberg, Robert; Cassella, James; Kunta, Jeevan; Hellriegel, Edward; Smith, Mark A.; Vinks, Alexander A.; Rabinovich‐Guilatt, Laura Journal: Journal of clinical pharmacology Issue: Volume 57:Number 10(2017) Page Start: 1244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 3 Study Evaluating Brexanolone, a GABAA Receptor Modulator, in Moderate Postpartum Depression [25H]. (May 2018) Authors: Kanes, Stephen; Colquhoun, Helen; Riesenberg, Robert; Rubinow, David; Maximos, Bassem; Meltzer-Brody, Samantha Journal: Obstetrics and gynecology Issue: Volume 131(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase 3 Study Evaluating Brexanolone, a GABAA Receptor Modulator, in Severe Postpartum Depression [29B]. (May 2018) Authors: Meltzer-Brody, Samantha; Kanes, Stephen; Riesenberg, Robert; Rubinow, David; Maximos, Bassem; Colquhoun, Helen Journal: Obstetrics and gynecology Issue: Volume 131(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache. Issue 10 (11th November 2020) Authors: Kudrow, David; Andrews, J. Scott; Rettiganti, Mallikarjuna; Oakes, Tina; Bardos, Jennifer; Gaul, Charly; Riesenberg, Robert; Wenzel, Richard; Kuruppu, Dulanji; Martinez, James Journal: Headache Issue: Volume 60:Issue 10(2020) Page Start: 2254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗